A regulatory Apologia — A review of placebo-controlled studies in regulatory submissions of new-generation antidepressants
- 1 September 2008
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 18 (9) , 623-627
- https://doi.org/10.1016/j.euroneuro.2008.06.003
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug AdministrationPLoS Medicine, 2008
- Selective Publication of Antidepressant Trials and Its Influence on Apparent EfficacyNew England Journal of Medicine, 2008
- Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applicationsBMJ, 2003
- Severity of Depression and Response to Antidepressants and Placebo: An Analysis of the Food and Drug Administration DatabaseJournal of Clinical Psychopharmacology, 2002
- Severity of depression and benzodiazepine comedication in relationship to efficacy of antidepressants in acute trials. A meta‐analysis of moclobemide trialsHuman Psychopharmacology: Clinical and Experimental, 1993
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986